Follow
Jeffrey Bradley
Jeffrey Bradley
Professor of Radiation Oncology, Emory University
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
Stereotactic body radiation therapy for inoperable early stage lung cancer
R Timmerman, R Paulus, J Galvin, J Michalski, W Straube, J Bradley, ...
Jama 303 (11), 1070-1076, 2010
27502010
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or …
JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ...
The lancet oncology 16 (2), 187-199, 2015
20022015
Radiation dose–volume effects in the lung
LB Marks, SM Bentzen, JO Deasy, JD Bradley, IS Vogelius, I El Naqa, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S70-S76, 2010
12162010
Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer
J Bradley, WL Thorstad, S Mutic, TR Miller, F Dehdashti, BA Siegel, ...
International Journal of Radiation Oncology* Biology* Physics 59 (1), 78-86, 2004
7632004
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis
DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ...
International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013
6942013
Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized …
SG Chun, C Hu, H Choy, RU Komaki, RD Timmerman, SE Schild, ...
Journal of Clinical Oncology 35 (1), 56, 2017
6832017
A method for the reconstruction of four‐dimensional synchronized CT scans acquired during free breathing
DA Low, M Nystrom, E Kalinin, P Parikh, JF Dempsey, JD Bradley, S Mutic, ...
Medical physics 30 (6), 1254-1263, 2003
6482003
Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung …
J Bradley, MV Graham, K Winter, JA Purdy, R Komaki, WH Roa, JK Ryu, ...
International Journal of Radiation Oncology* Biology* Physics 61 (2), 318-328, 2005
5912005
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response
JA Ajani, K Winter, GS Okawara, JH Donohue, PWT Pisters, CH Crane, ...
Journal of clinical oncology 24 (24), 3953-3958, 2006
5252006
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
F Dehdashti, MA Mintun, JS Lewis, J Bradley, R Govindan, R Laforest, ...
European journal of nuclear medicine and molecular imaging 30, 844-850, 2003
4242003
Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer
JD Bradley, C Hu, RR Komaki, GA Masters, GR Blumenschein, SE Schild, ...
Journal of Clinical Oncology 38 (7), 706, 2020
4122020
Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG oncology/RTOG 0813 trial
A Bezjak, R Paulus, LE Gaspar, RD Timmerman, WL Straube, WF Ryan, ...
Journal of Clinical Oncology 37 (15), 1316, 2019
4072019
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus
T Ritter, DJ Quint, S Senan, LE Gaspar, RU Komaki, CW Hurkmans, ...
International Journal of Radiation Oncology* Biology* Physics 81 (5), 1442-1457, 2011
3802011
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen
L Henke, R Kashani, C Robinson, A Curcuru, T DeWees, J Bradley, ...
Radiotherapy and Oncology 126 (3), 519-526, 2018
3712018
18f-fdg pet definition of gross tumor volume for radiotherapy of non–small cell lung cancer: Is a single standardized uptake value threshold approach appropriate?
KJ Biehl, FM Kong, F Dehdashti, JY Jin, S Mutic, I El Naqa, BA Siegel, ...
Journal of Nuclear Medicine 47 (11), 1808-1812, 2006
3552006
Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial
RD Timmerman, R Paulus, HI Pass, EM Gore, MJ Edelman, J Galvin, ...
JAMA oncology 4 (9), 1263-1266, 2018
3232018
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study
JD Bradley, F Dehdashti, MA Mintun, R Govindan, K Trinkaus, BA Siegel
Journal of clinical oncology 22 (16), 3248-3254, 2004
3052004
Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma
JD Bradley, N Ieumwananonthachai, JA Purdy, TH Wasserman, ...
International Journal of Radiation Oncology* Biology* Physics 52 (1), 49-57, 2002
3042002
Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer
TD Crabtree, CE Denlinger, BF Meyers, I El Naqa, J Zoole, AS Krupnick, ...
The Journal of thoracic and cardiovascular surgery 140 (2), 377-386, 2010
2962010
Novel breathing motion model for radiotherapy
DA Low, PJ Parikh, W Lu, JF Dempsey, SH Wahab, JP Hubenschmidt, ...
International Journal of Radiation Oncology* Biology* Physics 63 (3), 921-929, 2005
2732005
The system can't perform the operation now. Try again later.
Articles 1–20